Clinical Significance of Stem Cell or Myeliod Antigen Expression in Children with T-cell Acute Lymphoblastic Leukemia

刘秋霞,蒋黎明,薛惠良,陈静,潘慈,董璐,周敏,叶启东,江华,沈树红,顾龙君,汤静燕

2010-01-01

Abstract:Objective To investigate the prognosis of children T-oell acute lymphoblastic leukemia(T-ALL) with stem cell or myeloid antigen. Methods A total of 57 children with T-cell ALL or lymphoblastic non-Hodgkin' s lymphoma metastasized to bone marrow were subclassified into stem cell or myeliod antigen positive T-ALL(T/My+ALL) and stem cell or myeloid antigen negative T-ALL (T/My-ALL). Results Totally 31 (54.6% ) cases were T/My+ALL, and 26 (45.4%) T/My-ALL. There was no relationship between stem cell or myeloid antigen expression and cyto-morphology, genetics and clinical characters in T-ALL(P > 0.05); T/My+ALL was not different from T/My-ALL in 7 days prednisone inducement (P > 0.05). But compared with T/My-ALL, T/My + ALL patients had a poor result on day 19 inductiontherapy (P=0.002), and a low complete remission rate on day 35 induction therapy (P = 0.006). The complete remission rates of T/My+ALL and T/My-ALL were 90.3% and 96.2%; 5-year event-free survival (EFS) was 35.4% and 65.7% respectively, though it indicated T/My + ALL patients had a poor prognosis; there was no significance {P > 0.05). Conclusion Stem cell or myeloid antigen expression in T-ALL/NHL can not be considered as a poor prognosis factor by now.